MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
form 
Route of 
administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/07/419/001 
Cervarix 
EU/1/07/419/002 
Cervarix 
EU/1/07/419/003 
Cervarix 
EU/1/07/419/004 
Cervarix 
EU/1/07/419/005 
Cervarix 
EU/1/07/419/006 
Cervarix 
EU/1/07/419/007 
Cervarix 
EU/1/07/419/008 
Cervarix 
EU/1/07/419/009 
Cervarix 
EU/1/07/419/010 
Cervarix 
EU/1/07/419/011 
Cervarix 
EU/1/07/419/012 
Cervarix 
--1 
--1 
--1 
--1 
--1 
--1 
--1 
--1 
--1 
--1 
--1 
--1 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Suspension for 
injection 
Intramuscular use 
vial (glass) 
0.5 ml 
1 vial 
Intramuscular use 
vial (glass) 
0.5 ml 
10 vials 
Intramuscular use 
vial (glass) 
0.5 ml 
100 vials 
Intramuscular use 
Intramuscular use 
Intramuscular use 
Intramuscular use 
Intramuscular use 
Intramuscular use 
Intramuscular use 
pre-filled syringe 
(glass) 
pre-filled syringe 
(glass) 
pre-filled syringe 
(glass) 
pre-filled syringe 
(glass) 
pre-filled syringe 
(glass) 
pre-filled syringe 
(glass) 
vial (glass) 
Intramuscular use 
vial (glass) 
Intramuscular use 
vial (glass) 
0.5 ml 
0.5 ml 
0.5 ml 
0.5 ml 
0.5 ml 
0.5 ml 
1 ml 
1 ml 
1 ml 
1 pre-filled syringe  
+ 1 needle 
1 pre-filled syringe  
+ 2 needles 
10 pre-filled syringes 
+ 10 needles 
10 pre-filled syringes 
+ 20 needles 
1 pre-filled syringe 
10 pre-filled syringes 
1 vial (multidose) 
10 vials (multidose) 
100 vials (multidose) 
--1  1 dose (0.5 ml) contains: 
Human Papillomavirus1 type 16 L1 protein2,3,4  
Human Papillomavirus1 type 18 L1 protein2,3,4  
20 micrograms 
20 micrograms 
1Human Papillomavirus = HPV 
2adjuvanted by AS04 containing: 
3-O-desacyl-4â€™- monophosphoryl lipid A (MPL)3 
3adsorbed on aluminium hydroxide, hydrated (Al(OH)3)  
4L1 protein in the form of non-infectious virus-like particles (VLPs) produced by recombinant DNA technology using a Baculovirus expression system which uses Hi-5 
Rix4446 cells derived from Trichoplusia ni. 
0.5 milligrams Al3+ in total 
             50 micrograms 
 
 
 
 
 
 
 
